Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Study to Assess the Sustained Virological Suppression and Improvement of Treatment-emerged Adverse Events of Switching to Raltegravir in Stable HIV-infected Patients on Ritonavir-boosted Protease Inhibitor Regimen

NCT01679964 is registered in ClinicalTrials.gov with Lin, Hsi-Hsun, M.D. as lead sponsor.

NCT NCT01679964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Study to Assess the Sustained Virological Suppression and Improvement of Treatment-emerged Adverse Events of Switching to Raltegravir in Stable HIV-infected Patients on Ritonavir-boosted Protease Inhibitor Regimen
Lead sponsor
Lin, Hsi-Hsun, M.D.
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2012
Completion date
February 28, 2015
Enrollment
107 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reaction, hiv infection, quality of life